IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN)
World Wide Web version prepared by G. P. Moss
Department of Chemistry, Queen Mary University of London,
Mile End Road, London, E1 4NS, UK
These Rules are as close as possible to the published version [see Arch. Biochem. Biophys., 1974, 162, 1-5; Biochem. J., 1974, 137, 417-421; Biochemistry, 1974, 13, 1056-1058; Biochim. Biophys. Acta, 1974, 354, 155-159; Eur. J. Biochem., 1973, 40, 325-327; Pure Appl. Chem., 1973, 33, 445-452; Biochemical Nomenclature and Related Documents, 2nd edition, Portland Press, 1992, pages 269-271. A PDF of the printed version is available. Copyright IUPAC and IUBMB; reproduced with the permission of IUPAC and IUBMB]. If you need to cite these rules please quote these references as their source. In setting up the World Wide Web version some errors were detected and appropriate corrections have been made. The changes have been marked by which is a link to details of the change and where it applies.
Any comments should be sent to any member of the Committee
Vitamin B-6 Phosphates
Derivatives and Analogues
Use of Symbols in the Designation of Derivatives and Analogues
Note. This document is a revision of proposals published as Tentative Nomenclature Appendix No. 6 to IUPAC Information Bulletin, September, 1970 which were, in turn, an extension and revision of Section M-7 of the earlier IUPAC-IUB Tentative Rules, Trivial Names of Miscellaneous Compounds of Importance in Biochemistry Introduction
The first naturally occurring form of vitamin B-6 was isolated in 1938. It has the structure, confirmed by chemical synthesis (1939), of 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine (I; R = -CH2OH). The trivial name "pyridoxine", proposed for this compound by P. György, came into general use as a synonym for "vitamin B-6". Two other natural compounds possessing vitamin B-6 activity detected in 1944 and recognized as the aldehyde, or 4-formyl analogue (I; R = -CHO) of pyridoxine, and the corresponding amine, or 4-aminomethyl analogue (I; R = -CH2NH2), were designated "pyridoxal" and "pyridoxamine" respectively.
Note. The systematic name for I; R = -CH2OH, by IUPAC Organic Rule C-204.1, is 4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol.Within the next few years, I. C. Gunsalus, E. E. Snell, A. E. Braunstein and others demonstrated that a phosphoric derivative of pyridoxal, later identified as pyridoxal 5'-phosphate (II; R = -CHO), is the coenzyme of a large group of specific enzymes catalysing reactions of amino-group transfer, decarboxylation and other metabolic transformations of individual amino acids. In the course of enzymic transamination, pyridoxal 5'-phosphate undergoes reversible conversion into pyridoxamine 5'-phosphate (II; R = -CH2NH2), which has coenzyme activity for the aminotransferases (EC 2.6.1.-), but not for other types of vitamin B-6-dependent enzymes [2,3].
In the IUPAC Definitive Rules for the Nomenclature of Vitamins, published in 1960 , the term "pyridoxine" was recommended as a generic designation of the B-6 vitamins, and "pyridoxol" as the trivial name for the alcohol form (I; R = -CH2OH) previously designated as pyridoxine (Rule V-7). In the IUPAC-IUB Tentative Rules of 1966  for the nomenclature of vitamins and related compounds (Rule M-7.1), it was suggested that the latter compound should be designated "pyridoxine" or "pyridoxol" (see 7.1 below).
One regrettable consequence of these conflicting recommendations, giving rise to justified criticism, is the continuing use of the word "pyridoxine" in two different meanings - as a generic term for substances with vitamin B-6 activity, and as the trivial name of a definite chemical compound (which, incidentally, is one of the less abundant among the naturally occurring forins of vitamin B-6).
An extensive literature has accumulated on the chemistry and biochemistry of the B-6 vitamins and coenzymes, of their metabolites and of many related synthetic compounds that often exhibit biological activity as substitutes for or as antagonists of the corresponding natural products. A number of trivial and semitrivial names, sometimes incorrect or ambiguous, have been coined for vitamin B-6 derivatives and analogues, and several forms of abbreviated designations for these compounds have been introduced. For example, the abbreviations pyridoxal-P, P-pyridoxal, PLP (the symbol used most frequently), PALP, PalP, PALPO are in use for pyridoxal 5'-phosphate, and similar abbreviated forms have been used for other members of the group and their derivatives.
The IUPAC-IUB Commission on Biochemical Nomenclature (CBN), at its meeting in June 1968, decided to publish a special document, extending Section M-7 of the 1966 Rules , to put in order the nomenclature of the vitamin B-6 field and to unify relevant abbreviations for use in situations where this is essential. The present Recommendations are based on drafts prepared by A. E. Braunstein and E. E. Snell after consultation with other workers active in the field.
Rules (replacing Section M-7 of )
The term vitamin B-6 should be used as the generic descriptor for all 3-hydroxy-2-methylpyridine derivatives exhibiting qualitatively in rats the biological activity of pyridoxine. This term should be used in derived terms such as vitamin B-6 deficiency, vitamin B-6 activity, vitamin B-6 antagonists [5,6].
Comment. "Pyridoxine" should not be used as a generic name synonymous with "vitamin B-6" [5,6].
Note. The previous synonym, pyridoxol, (see Introduction and ) is no longer recommended.7.2. Compound I (R = -CHO) should be designated pyridoxal. The bivalent radical formed by removal of the oxygen atom from the CHO group is named pyridoxylidene.
7.3. Compound I (R = -CH2NH2) should be designated pyridoxamine.
7.4. The commonly occurring oxidized metabolites of pyridoxal, namely 3-hydroxy-5-hydroxymethyl-2-methylpyridine-4-carboxylic acid (III) and the corresponding lactone (IV), should be designated 4-pyridoxic acid and 4-pyridoxolactone respectively. (Three less commonly occurring metabolites of pyridoxine, formed by oxidation at position 5', have also been detected, namely the aldehyde, the carboxylic acid and its lactone; they have been designated by the trivial names "isopyridoxal", "5-pyridoxic acid" and "5-pyridoxolactone" respectively.)
Vitamin B-6 Phosphates
7.5. The 5'-phosphoric esters of pyridoxine, pyridoxal and pyridoxamine (II; R = -CH2OH, -CHO, -CH2NH2) should be designated pyridoxine 5'-phosphate (or pyridoxine-5'-P), pyridoxal 5'-phosphate (or pyridoxal-5'-P) and pyridoxamine 5'-phosphate (or pyridoxamine-5'-P) respectively. The positional numeral, 5'-, may be omitted where no ambiguity arises (in biochemical papers, etc.); e.g. pyridoxal 5'-phosphate may be abbreviated pyridoxal-P.
For convenience (for example in names of derived compounds), it is admissible to use the symbol P (for "phosphoric ester") as a prefix, for example: N6-(5'-P-pyridoxyl)-L-lysine; P-pyridoxylideneimines.
Derivatives and Analogues
7.6. From the trivial names already indicated, semitrivial names for various derivatives and analogues of the B-6 vitamins and their phosphoric esters (coenzyme analogues) can be constructed according to the conventional rules of organic nomenclature (see also 7.9).
2-demethylpyridoxal or 2-norpyridoxal,
2-propyl-2-norpyridoxal, or 2'-ethylpyridoxal (not -ethylpyridoxal),
6-methylpyridoxal (Compound V),
2'-hydroxypyridoxal (2-hydroxymethyl-2-demethylpyridoxal, 2-hydroxymethyl-2-norpyridoxal; not -hydroxypyridoxal),
5'-methylpyridoxal-5'-P (Compound VI),
pyridoxal N-oxide 5'-phosphate.
7.7. As noted in the Introduction, many abbreviations have been used in the past to represent the three principal forms of vitamin B-6, their phosphoric esters and analogues in the text of papers. Those listed in column 2 of the Table 1 have achieved prominence as the favoured forms. Their use in text in place of the approved trivial names (column 1), which are sufficiently short, is not recommended. It is admissible to use the abbreviations, with ad hoc definition in each paper (and with the consent of the editors concerned), when necessary in cases of space restriction, e.g. in tables, in figures and in extensive lists of derivatives and their reactions.
Table 1. Abbreviated designations
|Trivial name (abridged) a||Abbreviation b|
a Recommended for use in text.
b Previous major abbreviations; not recommended for use in text. Admissible (with ad hoc definition) in special cases, e.g. when required by space limitations (see 7.7); they may also be combined with approved symbols (7) for commonly occurring substituents, e.g. 6MePL (Compound V). Compounds involving the pyridoxyl or pyridoxylidene radical should generally be symbolized as indicated in Paragraph 7.8 (see ). For isotopic replacement, see Paragraph 7.9.
Use of Symbols in the Designation of Derivatives and Analogues
7.8. Pyridoxyl (7.1) and pyridoxylidene (7.2) groups and similar residues of vitamin B-6 phosphates and analogues (7.5, 7.6) frequently occur in natural substances (B-6-dependent enzymes), and in modified or synthetic products (e.g. enzymes reconstituted with coenzyme analogues or reduced with borohydride or both) in combination with amino-acid or peptide residues.
To represent such derivatives in condensed forms similar to those recommended for substituted polypeptides, it is suggested to use the following symbols:
Pxy- (having a single bond) for the pyridoxyl group.
Pxd= (having a double bond) for the pyridoxylidene group
The corresponding 5'-phosphorylated residues may be designated by adding the symbols P as a hyphenated prefix or suffix, and common alkyl or acyl substituents by prefixes in parentheses, composed from the recommended symbols and their locants [7-9].
PxyLys- or or or Lys(Pxy) for the N6-pyridoxyl-L-lysine residue
P-PxyLys- or or or Lys(P-Pxy) for the N6-(P-pyridoxyl)-L-lysine residue
Note The latter two symbols are more suitable for use in sequences (see last three examples).
PxdLys, etc., P-PxdLys, etc., for the N6-pyridoxylidene-L-lysine residue and its phosphoric ester
PxyLys-, or Pxy-Val, etc., for N2-pyridoxyl-L-lysine residue and other N2-pyridoxyl-L-amino-acid residues (in N-terminal position).
P-PxyLys-, P-Pxy-Val, etc., for the corresponding N2(P-pyridoxyl)-L-amino-acid residues.
Pxd=Val-, P-Pxd=Val-, etc., for N2-pyridoxylidene-L-amino-acid residues and the corresponding phosphoric esters
P-(3deoxy)PxdLys-, for the N6-(3-deoxy-5'-P-pyridoxylidene)-L-lysine residue
, for an N6-(3-O-methyl-2-nor-5'-P) pyridoxyl-L-lysine residue in a peptide sequence
, for an N6-(6-methylpyridoxylidene)-L-lysine residue in a peptide sequence
, for a hypothetical pyridoxal-5'-P-3-O-L-Serine (phosphodiester) residue in a peptide sequence.
7.9. Isotopic replacement in B-6 vitamins, coenzymes, and derivatives can be designated by the conventional notations.
[3-18O]pyridoxal-P, for pyridoxal 5'-phosphate labeled with 18O at O-3
6-[3H]methylpyridoxamine-[32P]P, for 6-methylpyridoxamine 5'-phosphate with tritium at C-6' and 32P in the phosphate group
, for a peptide sequence with an N6-pyridoxylidene-L-lysine residue labeled with 14C at C-2'.
1. IUPAC-IUB Commission on Biochemical Nomenclature (1967) Eur. J. Biochem. 2, 1-2; and elsewhere.
2. Snell, E. E. (1958) Vitam. Horm. 16, 77.
3. Braunstein, A. E. (1960) in The Enzymes, 2nd edn (Boyer, P. D., Lardy, H. & Myrbäck, K., eds) p. 113, Academic Press, New York.
4. International Union of Pure and Applied Chemistry (1960) J. Am. Chem. Soc. 82, 5581.
5. International Union of Nutritional Sciences (1970) Nutr. Abstr. Rev. 40, 395.
6. American Institute of Nutrition (1971) J. Nutr. 101, 133.
7. IUPAC-IUB Commission on Biochemical Nomenclature (1972) Eur. J. Biochem. 27, 201-207; and elsewhere. [Now incorporated in the 1983 recommendations for amino acids and peptides.]
8. IUPAC-IUB Commission on Biochemical Nomenclature (1967) Eur. J. Biochem. 1, 259-266; and elsewhere.
9. IUPAC-IUB Commission on Biochemical Nomenclature (1970) Eur. J. Biochem. 15, 203-208; and elsewhere. [Now available as a web version.]